Passage Bio (PASG) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

PASG is expected to report earnings to fall 34.39% to -20 cents per share on February 27

Q4'24

Est.

$-0.20

Q3'24

Missed

by $0.08

Q2'24

Beat

by $0.05

Q1'24

Beat

by $0.05

Q4'23

Beat

by $0.09

The last earnings report on November 13 showed earnings per share of -31 cents, missing the estimate of -23 cents. With 239.14K shares outstanding, the current market capitalization sits at 36.46M.

View a ticker or compare two or three

Compare

PASG

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For PASG
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a genetic medicines company, which focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2005 Market Street

Phone

+1 267 866-0311

Employees

Web

https://www.passagebio.com